We are a global leader in the development, manufacture and marketing of medical devices for the eye. We market and sell products through three major strategic business units (“SBUs”): cataract, refractive, and eye care. In the cataract SBU, we focus on the four key products required for cataract surgery — monofocal intraocular lenses (“monofocal IOLs”), implantation systems, phacoemulsification systems and viscoelastics. In the refractive SBU, we market excimer and femtosecond laser systems, related treatment cards and disposable patient interfaces, related diagnostic devices and refractive implants. Our eye care SBU provides a full range of contact lens care products for use with a wide range of contact lenses. Our products include single-bottle, multi-purpose cleaning and disinfecting solutions, hydrogen peroxide-based disinfecting solutions, daily cleaners, enzymatic cleaners and contact lens rewetting drops. In 2008, we also introduced eye drops designed to treat the symptoms of dry eye. The products across our three SBUs are sold in approximately 60 countries and we have direct operations in approximately 27 countries. In June 2004, we completed our acquisition of Pfizer Inc.’s surgical ophthalmic business, which expanded our viscoelastic and intraocular lens (“IOL”) product offerings, allowing us to offer a more comprehensive portfolio of products required to perform cataract surgery. We acquired the Healon family of viscoelastic products and the Tecnis IOL brand. The addition of the Healon family, a leading viscoelastic brand, significantly expanded our viscoelastic product line. The Tecnis IOL brand further strengthened our position in the ophthalmic surgery market with the Tecnis Multifocal IOL brand further expanding our refractive IOL portfolio. We also acquired the Baerveldt glaucoma shunt, or drainage device, which provided an entry for us into the glaucoma market.
Company profile
Website
CEO
L. Reade Fahs
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Advanced Medical Optics Inc
SEC CIK
Corporate docs
IRS number
330986820
Latest filings (excl ownership)
15-12B
Securities registration termination
17 Mar 09
S-8 POS
Registration of securities for employees (post-effective amendment)
17 Mar 09
S-8 POS
Registration of securities for employees (post-effective amendment)
17 Mar 09
S-8 POS
Registration of securities for employees (post-effective amendment)
17 Mar 09
S-8 POS
Registration of securities for employees (post-effective amendment)
17 Mar 09
S-8 POS
Registration of securities for employees (post-effective amendment)
17 Mar 09
S-8 POS
Registration of securities for employees (post-effective amendment)
17 Mar 09
25-NSE
Exchange delisting
27 Feb 09
8-K
Offer to Repurchase for Cash
27 Feb 09
POSASR
Automatic shelf registration (post-effective amendment)
26 Feb 09
Latest ownership filings
11-K
Annual report of employee stock purchases
26 Jun 08
11-K
Annual report of employee stock purchases
27 Jun 07
11-K
Annual report of employee stock purchases
29 Jun 06
11-K
Annual report of employee stock purchases
27 Jun 05
11-K
Annual report of employee stock purchases
25 Jun 04
11-K
Annual report of employee stock purchases
30 Jun 03